Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIIIW) Operating Leases (2020 - 2025)

Historic Operating Leases for P3 Health Partners (PIIIW) over the last 5 years, with Q3 2025 value amounting to $12.1 million.

  • P3 Health Partners' Operating Leases rose 802.12% to $12.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.1 million, marking a year-over-year increase of 802.12%. This contributed to the annual value of $11.3 million for FY2024, which is 1675.97% down from last year.
  • Latest data reveals that P3 Health Partners reported Operating Leases of $12.1 million as of Q3 2025, which was up 802.12% from $10.3 million recorded in Q2 2025.
  • P3 Health Partners' Operating Leases' 5-year high stood at $13.6 million during Q4 2023, with a 5-year trough of $6.3 million in Q1 2022.
  • For the 4-year period, P3 Health Partners' Operating Leases averaged around $11.5 million, with its median value being $11.5 million (2022).
  • Its Operating Leases has fluctuated over the past 5 years, first skyrocketed by 10263.18% in 2023, then tumbled by 1768.96% in 2024.
  • Quarter analysis of 4 years shows P3 Health Partners' Operating Leases stood at $11.5 million in 2022, then increased by 18.29% to $13.6 million in 2023, then decreased by 16.76% to $11.3 million in 2024, then rose by 6.3% to $12.1 million in 2025.
  • Its last three reported values are $12.1 million in Q3 2025, $10.3 million for Q2 2025, and $11.0 million during Q1 2025.